COMPANY
Alloy Therapeutics
Hiring
| Title | Location (from posting) | Employer posted | First seen |
|---|---|---|---|
| Senior Executive Assistant, Technology & National Security | Waltham, MA | Not stated | Oct 23, 2026 |
| VP, Business Operations, Technology & National Security | Waltham, MA | Not stated | Oct 23, 2026 |
| 82VS Venture Partner | Waltham, MA | Not stated | Oct 11, 2026 |
| Associate Director - Antibody Discovery Programs | Waltham, MA | Not stated | Oct 11, 2026 |
| Associate Director, Antibody Discovery | Athens, GA | Not stated | Oct 11, 2026 |
Funding and NIH signals
- SEC Form D raise Raised $30.02M (Form D filed Apr 15, 2026); 15 roles open. SEC Form D 0001851943-26-000001 (Apr 15, 2026)
Evidence (1 event)
- Apr 15, 2026 · SEC Form D 0001851943-26-000001
Name of Issuer: Alloy Therapeutics, Inc.; CIK: 1851943; Address: Waltham, MA; Submission type: D; Filing date: 2026-04-15; Industry Group: Biotechnology; Date of First Sale: 2026-03-31; Types of Securities Offered: Equity; Business combination transaction: false; Total Offering Amount: 39999940; Total Amount Sold: 30020259; Federal exemptions: 06b
- Apr 15, 2026 · SEC Form D 0001851943-26-000001
Raises and deals from press releases
- Raise Series E · $40M · announced Apr 15, 2026 Company release ↗
Source quote
- Apr 15, 2026 · Company release ↗
“Alloy Therapeutics Announces $40M Series E to Scale Tech-Enabled Biotech Infrastructure”
- Apr 15, 2026 · Company release ↗
- Deal Biogen deal · amount not disclosed · announced Apr 7, 2026 Company release ↗
Source quote
- Apr 7, 2026 · Company release ↗
“Alloy Therapeutics Enters into Multi-Target Collaboration and License Agreement with Biogen for Use of Alloy’s AntiClastic™ ASO Platform”
- Apr 7, 2026 · Company release ↗
- Deal Deal · amount not disclosed · announced Feb 11, 2025 Company release ↗
Source quote
- Feb 11, 2025 · Company release ↗
“Alloy Therapeutics Establishes Multi-Year Collaboration with Pfizer to Develop New Antibody Discovery Platform”
- Feb 11, 2025 · Company release ↗
- Deal Sanofi deal · amount not disclosed · announced Jan 7, 2025 Company release ↗
Source quote
- Jan 7, 2025 · Company release ↗
“Alloy Therapeutics Announces a Target Specific Collaboration and License Agreement for use of AntiClastic™ Antisense Platform with Sanofi”
- Jan 7, 2025 · Company release ↗
Timeline
- Partnership Partnership / licensing announced Jun 18, 2026. Source: company's own press page. source ↗
- Partnership Partnership / licensing announced May 5, 2026. Source: company's own press page. source ↗
- Raise Series E · $40M source ↗
- Partnership Partnership / licensing announced Jul 21, 2025. Source: company's own press page. source ↗
- Partnership Partnership / licensing announced Jan 7, 2025. Source: company's own press page. source ↗
- Partnership Partnership / licensing announced Oct 29, 2024. Source: company's own press page. source ↗
Funding
- Partnership / licensing announced Jun 18, 2026. Source: company's own press page. source ↗
- Partnership / licensing announced May 5, 2026. Source: company's own press page. source ↗
- Partnership / licensing announced Jul 21, 2025. Source: company's own press page. source ↗
- Partnership / licensing announced Jan 7, 2025. Source: company's own press page. source ↗
- Partnership / licensing announced Oct 29, 2024. Source: company's own press page. source ↗
Open jobs 17
| Title | Location (from posting, not HQ) | Employer posted | First seen | Level |
|---|---|---|---|---|
| Senior Executive Assistant, Technology & National Security | Waltham, MA | Not stated | Oct 23, 2026 | Not stated |
| VP, Business Operations, Technology & National Security | Waltham, MA | Not stated | Oct 23, 2026 | Not stated |
| 82VS Venture Partner | Waltham, MA | Not stated | Oct 11, 2026 | Mid |
| Associate Director - Antibody Discovery Programs | Waltham, MA | Not stated | Oct 11, 2026 | Senior |
| Associate Director, Antibody Discovery | Athens, GA | Not stated | Oct 11, 2026 | Senior |
| Associate Scientist – In Vitro Discovery | Waltham, MA | Not stated | Oct 11, 2026 | Mid |
| Chief Product Officer (CPO) of Antibody-Powered Division (APD) | Waltham, MA | Not stated | Oct 11, 2026 | Executive |
| Director, Protein Science | Waltham, MA | Not stated | Oct 11, 2026 | Senior |
| Head of Cell Line Development | Waltham, MA | Not stated | Oct 11, 2026 | Executive |
| Marketing Specialist | Waltham, MA | Not stated | Oct 11, 2026 | Mid |
| Scientific Operations Manager / Associate Scientist, Oligonucleotide Synthesis & Analytical Sciences | Waltham, MA | Not stated | Oct 11, 2026 | Mid |
| Scientist I – Molecular Biology | Cambridge, United Kingdom | Not stated | Oct 11, 2026 | Not stated |
| Scientist II or Senior Scientist, Protein Analytics | Waltham, MA | Not stated | Oct 11, 2026 | Mid |
| Submit Your CV for Future Openings | United States | Not stated | Oct 11, 2026 | Not stated |
| Global Bioanalytics Co-op | Waltham, MA | Not stated | Oct 11, 2026 | Not stated |
| In Vitro Pharmacology Co-op | Waltham, MA | Not stated | Oct 11, 2026 | Not stated |
| Protein Science Co-op | Waltham, MA | Not stated | Oct 11, 2026 | Not stated |
Connect
See your connections at Alloy Therapeutics on LinkedIn (search by name, results not checked)